Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Biomedical Engineering
SJR: 0.207 SNIP: 0.376 CiteScore™: 0.79

ISSN Imprimir: 0278-940X
ISSN En Línea: 1943-619X

Volumes:
Volumen 47, 2019 Volumen 46, 2018 Volumen 45, 2017 Volumen 44, 2016 Volumen 43, 2015 Volumen 42, 2014 Volumen 41, 2013 Volumen 40, 2012 Volumen 39, 2011 Volumen 38, 2010 Volumen 37, 2009 Volumen 36, 2008 Volumen 35, 2007 Volumen 34, 2006 Volumen 33, 2005 Volumen 32, 2004 Volumen 31, 2003 Volumen 30, 2002 Volumen 29, 2001 Volumen 28, 2000 Volumen 27, 1999 Volumen 26, 1998 Volumen 25, 1997 Volumen 24, 1996 Volumen 23, 1995

Critical Reviews™ in Biomedical Engineering

DOI: 10.1615/CritRevBiomedEng.2014010464
pages 405-424

Has Percutaneous Aortic Valve Replacement Taken Center Stage in the Treatment of Aortic Valve Disease?

Gideon Praveen Kumar
Institute of High Performance Computing, A*STAR, Singapore
Fangsen Cui
Institute of High Performance Computing, A*STAR, Singapore
Lazar Mathew
Nanotech Research Facility, PSG Institute of Advanced Studies, Tamil Nadu, India
Hwa Liang Leo
Department of Biomedical Engineering, National University of Singapore, Singapore

SINOPSIS

Modern biomedical advances have propelled percutaneous valve replacement into an effective and powerful therapy for many heart valve diseases, especially aortic valve stenosis. Experiences so far suggest that outcomes for new percutaneous valve replacement surgery compare favorably with that of traditional valve surgery in selected patients with severe symptomatic aortic stenosis. The inception of percutaneous aortic valve replacement (PAVR) began in 1992 when the potential for treating valve diseases was demonstrated through a modern technique of endoluminal deployment of a catheter-mounted crimped stented heart valve in an animal model. The first successful demonstration of such novel technique of surgical replacement of a heart valve was performed in 2002, when valve implantation in a patient with aortic stenosis was reported. Despite initial stumbles and a perception of being an uphill task, PAVR has emerged as one of the breakthroughs in surgical procedures. More than 1500 citations were found in PubMed, half of which were available after 2011. This is primarily because more than 50,000 procedures are being performed in more than 40 countries wordwide, with encouraging outcomes, and several stented valves have been launched in the market. This review provides a detailed analysis of the current state of the art of PAVR. Moreover, a competitive landscape of various devices available in the market and their design considerations, biomaterial selections, and overall hemodynamic performance are presented.


Articles with similar content:

Fast-Dissolve Drug Delivery Systems
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.17, 2000, issue 1
John Hontz, Raj Khankari, Walid Habib
Digital Signal Processing of the Phonocardiogram: Review of the Most Recent Advancements
Critical Reviews™ in Biomedical Engineering, Vol.23, 1995, issue 3-4
Louis-Gilles Durand, Philippe Pibarot
Review: Most Recent Advancements in Digital Signal Processing of the Phonocardiogram
Critical Reviews™ in Biomedical Engineering, Vol.45, 2017, issue 1-6
Louis-Gilles Durand, Philippe Pibarot
Minimally Invasive Surgical Management of Ureteropelvic Junction Obstruction: Laparoscopic and Robot-Assisted Laparoscopic Pyeloplasty
Journal of Long-Term Effects of Medical Implants, Vol.13, 2003, issue 5
Joseph J. Del Pizzo, Dix Phillip Poppas, R. Ernest Sosa, Ravi Munver
Breast Implant Surveillance Reports to the U.S. Food and Drug Administration: Maternal-Child Health Problems
Journal of Long-Term Effects of Medical Implants, Vol.16, 2006, issue 4
S. Lori Brown, Hari Cheryl Sachs, Judith U. Cope, Joan Ferlo Todd